1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Financials
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Quote. Delayed Nasdaq - 05/27 04:00:00 pm
147.66 USD   +8.73%
08:09aSwitzerland to Throw Out 620,000 Expired Moderna COVID-19 Vaccine Shots
MT
05/26ZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect
05/26INSIDER SELL : Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 6 51841 340102 97654 016--
Enterprise Value (EV)1 5 54836 84292 84835 93532 41530 393
P/E ratio -12,6x-53,3x8,98x4,99x17,6x45,1x
Yield ------
Capitalization / Revenue 108x51,5x5,58x2,45x5,51x7,93x
EV / Revenue 92,1x45,9x5,03x1,63x3,31x4,46x
EV / EBITDA -10,8x-50,3x6,86x2,62x7,53x9,76x
Price to Book 6,14x16,3x7,24x2,15x1,80x1,63x
Nbr of stocks (in thousands) 333 250395 710405 450397 760--
Reference price (USD) 19,6104254136136136
Announcement Date 02/26/202002/25/202102/24/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 60,280318 47122 0699 7986 807
EBITDA1 -515-73213 52813 7134 3043 114
Operating profit (EBIT)1 -546-76313 29613 6884 6601 569
Operating Margin -906%-95,0%72,0%62,0%47,6%23,0%
Pre-Tax Profit (EBT)1 -515-74513 28513 6734 0621 211
Net income1 -514-74712 20211 5013 2431 314
Net margin -854%-93,0%66,1%52,1%33,1%19,3%
EPS2 -1,55-1,9628,327,27,703,01
Dividend per Share2 ------
Announcement Date 02/26/202002/25/202102/24/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 4 9697 2116 0664 1055 9326 128
EBITDA -5 488----
Operating profit (EBIT)1 3 5585 4104 2272 2263 5903 616
Operating Margin 71,6%75,0%69,7%54,2%60,5%59,0%
Pre-Tax Profit (EBT)1 3 5525 4104 2292 1503 7293 680
Net income1 3 3334 8683 6571 9142 9982 865
Net margin 67,1%67,5%60,3%46,6%50,5%46,8%
EPS2 7,7011,38,584,767,136,67
Dividend per Share ------
Announcement Date 11/04/202102/24/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 9714 49810 12818 08121 60123 623
Leverage (Debt / EBITDA) 1,89x6,15x-0,75x-1,32x-5,02x-7,59x
Free Cash Flow1 -4911 96013 3368 5014 8162 573
ROE (Net Profit / Equities) -38,0%-40,0%146%58,4%10,9%3,79%
Shareholders' equity1 1 3531 8688 35319 67829 71134 671
ROA (Net Profit / Asset) -28,9%-16,7%76,2%40,4%6,29%0,83%
Assets1 1 7764 46316 00328 46151 592158 862
Book Value Per Share2 3,196,4235,163,075,383,1
Cash Flow per Share2 -5,3231,619,96,291,36
Capex1 31,667,4284704544416
Capex / Sales 52,4%8,40%1,54%3,19%5,55%6,11%
Announcement Date 02/26/202002/25/202102/24/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 54 015 742 408
Net sales (USD) 18 471 000 000
Number of employees 2 700
Sales / Employee (USD) 6 841 111
Free-Float 90,6%
Free-Float capitalization (USD) 48 919 801 372
Avg. Exchange 20 sessions (USD) 1 103 035 955
Average Daily Capital Traded 2,04%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA